Lumanity

Alzheimer’s disease research has primarily focused on clinical cohorts, yet many patients are diagnosed and followed in primary care. Real-world data (RWD) can provide insight into disease trajectories. Read on: buff.ly/TLwwV26 #Dementia #Alzheimers #RWD #PrimaryCare

The new EMA Real-World Data Quality Framework (RW-DQF) makes one thing clear: it is not enough to have real-world data - you need to show it’s fit-for-purpose for the specific regulatory question. Read more: buff.ly/9fobJ3c #RWE #RWD #EMA #Regulatory #DataQuality

Yesterday, we proudly participated in and sponsored BioNJ’s 16th annual @BioPartnering conference at the Liberty Science Center in Jersey City. A big thanks to our onsite team. Let's keep the conversation going! Email contact@lumanity.com to connect! #BioNJ #Pharma #Biotech

Meet with our Oncology Center of Excellence at the upcoming ASCO annual meeting! Learn more about our Oncology expertise: buff.ly/z9RgW4Y and for a full list of the staff who will be at ASCO: buff.ly/PrIfbgb #ASCO26 #CancerResearch #OncologyExpertise

Sometimes the biggest obstacle to physical & mental health care isn’t the illness itself, but the system meant to treat it. In Episode 3 of Patient Progress, advocates share their experiences navigating healthcare systems: buff.ly/uwy31OJ

We're just a few weeks away from the 2026 Patients as Partners in Clinical Research EU conference in London! Catch our session, “Criteria for Patient Engagement Post Clinical Research Studies” and stop by booth 17 to connect! #PatientsEU2026 #PatientEngagement #PatientAdvocacy

We're counting down to the 2026 Pharma #SocialMedia Conference in London. If you'll be there, we encourage you to connect with Hannah Stewart or email contact@lumanity.com to schedule time to meet on site. #SocialMediaInsights #SocialMediaListening #HealthcareAnalytics

Our first vignette of our Voices of Rare Disease: Perspectives Across the Community series featured advocate İpek Badırgali. Now, we are sharing Ella Balasa’s story, offering a new perspective from the cystic fibrosis community. Hear their stories: buff.ly/4iWcEaC

Will you be at next week's 60th annual meeting of the European Diabetes Epidemiology Group (EDEG)? If so, be sure to catch our co-authored presentations! buff.ly/q904AfR #Epidemiology #Diabetes #PrimaryCare #RealWorldEvidence

AMCP 2026 confirmed a major shift: coverage no longer guarantees access. Payers are tightening policies, raising evidence standards, and exposing where patients drop off in the real world. Read our key takeaways from Nashville: buff.ly/qaYiCds #AMCP2026 #MarketAccess

Living with cystic fibrosis since early childhood and grounded in a background in science, Ella Balasa brings a perspective shaped by both lived experience and deep understanding of the care journey. Hear Ella’s story: buff.ly/4iWcEaC

Attending this week's British Healthcare Business Intelligence Association 2026 Annual Conference? If so, be sure to catch up with our attending experts, including Claire Mason, Megan Brown, and Chloe Ormond. #BHBIA2026 #BusinessIntelligence #HealthcareInsights

If you're building a biotech and medical affairs isn't at the table yet, this episode is for you. Listen anywhere you get your podcasts or here: buff.ly/5fvyGZc #MedicalAffairs #DrugDevelopment #ClinicalDevelopment #MarketAccess #Launch #MedicalAffairsUnscripted

We're looking forward to the 2026 CancerCare Spring Gala next week, and proud to be an event sponsor. If you'll be there, we'd love to say hi! For more information on the event, visit buff.ly/OujFfA0 #CancerCare #CancerResearch #Oncology

#ArtificialIntelligence #AI governance and oversight is vital for evidence synthesis, regulatory strategy, pricing decisions, #HTA, portfolio prioritization, and market access modeling. Learn more by checking out our article in Silicon Valleys Journal: buff.ly/CyuJ1ZG

Join us at the upcoming #ISMPPAnnual where we'll be exhibiting and presenting! Visit us at booth 11, meet our experts, and check out our new Evidence Navigator Hub and Expert Navigator platform. Explore more: buff.ly/7RMj3VJ #MedicalPublications #MedPubs #MedComms

In our recent webinar, "Using AI-driven synthetic personas to take your insights further," we cover how pharma teams are beginning to leverage synthetic personas. Check out the webinar highlights: buff.ly/oJyx43G #SyntheticPersonas #HealthcareInsights #AiInsights

Join us as we explore how to strategically design and implement #MSL-led content pathways anchored in a scientific narrative, seamlessly integrating them into a broader #omnichannel strategy. Register: buff.ly/6mDoB7q #MedicalScienceLiaisons #HCP #MedicalAffairs

We're just a couple weeks away from the 2026 #ClinicalOutcomeAssessment Program Annual Meeting in Washington, D.C. If you'll be at the meeting, let's connect! Email contact@lumanity.com to find time to meet. buff.ly/FDehTG3 #COA #OutcomesResearch #PatientReportedOutcomes

At the NICE Conference 2026 it was clear that the pace of change in UK HTA is accelerating, and organizations need to be ready. Our new article reflects on key themes from the conference and the implications for companies preparing for NICE engagement. buff.ly/0A5Fm34